A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of DOV 21,947 [EB-1010] in Patients With Major Depressive Disorder
Phase of Trial: Phase II
Latest Information Update: 01 Jan 2012
At a glance
- Drugs Amitifadine (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- Sponsors DOV Pharmaceutical
- 01 Jan 2012 Results published in the Journal of Psychiatric Research.
- 07 Sep 2011 Results presented at the 24th Annual Congress of the European College of Neuropsychopharmacology.
- 18 May 2011 Results presented at the 164th Annual Meeting of the American Psychiatric Association.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History